Quoin Pharma Files 10-Q for Q1 2025
Ticker: QNRX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials, fair-value
TL;DR
Quoin Pharma's Q1 2025 10-Q is in. Focus on pharma prep, fair value, and T-bills.
AI Summary
Quoin Pharmaceuticals, Ltd. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is based in Kfar Saba, Israel. The filing indicates a focus on pharmaceutical preparations and includes financial data related to fair value measurements and U.S. Treasury Bill securities.
Why It Matters
This filing provides investors with an update on Quoin Pharmaceuticals' financial health and operational status for the first quarter of 2025, including details on their assets and liabilities.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Quoin Pharmaceuticals operates in a highly regulated and competitive industry, which inherently carries significant risks.
Key Numbers
- 0.028 — Fair Value Measurement (Indicates a specific value related to fair value measurements, potentially for assets or liabilities.)
- 25000 — P13D (Likely refers to a specific financial instrument or disclosure, context requires further detail from the full filing.)
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer of the 10-Q
- Cellect Biotechnology Ltd. (company) — Former name of Quoin Pharmaceuticals
- Cellect Biomed Ltd. (company) — Former name of Quoin Pharmaceuticals
- 20250331 (date) — End of reporting period
- 20250513 (date) — Filing date
- Kfar Saba, Israel (location) — Company's business address
FAQ
What is the primary business of Quoin Pharmaceuticals, Ltd.?
Quoin Pharmaceuticals, Ltd. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was the reporting period for this 10-Q filing?
The Conformed Period of Report for this 10-Q filing was March 31, 2025.
What were Quoin Pharmaceuticals' former names?
Quoin Pharmaceuticals, Ltd. was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.
What types of securities are mentioned in relation to fair value measurements?
The filing mentions U.S. Treasury Bill Securities in relation to fair value measurements.
What is the company's business address?
The company's business address is 23 Hata'as Street, Kfar Saba, L3, 44425.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).